Haleon plc Asset Resilience Ratio
Haleon plc asset resilience ratio. Haleon plc (HLN) has an Asset Resilience Ratio of 4.06% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See HLN days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Haleon plc (2019–2025)
Asset resilience ratio of Haleon plc from 2019 to 2025. This chart shows how Haleon plc's Asset Resilience Ratio has changed over time. Read Haleon plc debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Haleon plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Haleon plc's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $1.32 Billion | 4.06% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $1.32 Billion | 4.06% |
Asset Resilience Insights
- Limited Liquidity: Haleon plc maintains only 4.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Haleon plc Industry Peers by Asset Resilience Ratio
Compare Haleon plc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 29.37% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321 |
Drug Manufacturers - Specialty & Generic | 5.10% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Haleon plc Asset Resilience Ratio by Year (2019–2025)
Haleon plc asset resilience ratio by year from 2019 to 2025. The table below shows the annual Asset Resilience Ratio data for Haleon plc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 1.30% | $424.00 Million | $32.57 Billion | +1.14pp |
| 2024-12-31 | 0.16% | $55.00 Million | $34.31 Billion | -2.03pp |
| 2022-12-31 | 2.19% | $762.00 Million | $34.81 Billion | +2.18pp |
| 2021-12-31 | 0.01% | $2.00 Million | $34.45 Billion | 0.00pp |
| 2020-12-31 | 0.01% | $2.00 Million | $34.13 Billion | +0.00pp |
| 2019-12-31 | 0.01% | $2.00 Million | $35.71 Billion | -- |
About Haleon plc
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; an… Read more